| Literature DB >> 33809896 |
Tihomir Kovač1,2, Tihana Marček1, Bojan Šarkanj2,3, Ivana Borišev4, Maja Ižaković1, Katarina Jukić5, Ante Lončarić1, Tamara Krska2, Michael Sulyok2, Rudolf Krska2,6.
Abstract
Fullerol C60(OH)24 nanoparticles (FNP)-wheat-A. flavus interaction outcome is more complicated in the presence of drought. This study sheds light on how the presence of FNP affects food and feed safety from the perspective of mycotoxin contamination. The study aims to determine the influence of FNP at environmentally plausible concentrations on wheat growth under drought stress and on the aggressiveness of A. flavus during wheat germination, as well as the influence of FNP on the secondary metabolite profile during the inappropriate wheat storage. The co-occurrence of drought and FNP inhibited germination and shoot growth, while an application of FNP alone had no negative effect on plant growth. Wheat pre-treated with FNP showed a concentration dependent resistance pattern to A. flavus aggressiveness. Nevertheless, using a LC-MS/MS based multi-mycotoxin method, six secondary fungal metabolites: 3-nitropropionic acid (<LOD -775.7336 ± 10.7752 ng mL-1), aflatoxin B1 (<LOD -6.78 ± 0.43 ng mL-1) and B2 (<LOD -0.07 ± 0.00 ng mL-1), aflatoxicol (<LOD -0.37 ± 0.16 ng mL-1), kojic acid (<LOD -1337.87 ± 189.04 ng mL-1), and O-methylsterigmatocystin (<LOD -0.17 ± 0.00 ng mL-1), were detected. FNP affected secondary metabolism of A. flavus during inappropriate wheat storage and increased the concentration of secondary metabolites in a concentration-dependent pattern (3-nitropropionic acid and kojic acid). In addition, aflatoxicol production was provoked in FNP treated samples.Entities:
Keywords: Aspergillus flavus NRRL 3251; drought; fullerol C60(OH)24 nanoparticles; mycotoxins; wheat (Triticum aestivum L.)
Year: 2021 PMID: 33809896 PMCID: PMC8004204 DOI: 10.3390/jof7030236
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Fullerol C60(OH)24 aqueous nanoparticles solution (c = 10 mg mL−1) size distribution by number (a) and apparent zeta potential (ζ) (b). Data represent one selected result out of three measurements with similar obtained values of mean hydrodynamic radius (a) and surface charge (b). - diameter of the fullerol C60(OH)24 aqueous nanoparticles.
Figure 2Germination percentage under drought (PEG), fullerol C60(OH)24 nanoparticles (FNP; 10, 100 and 1000 ng mL−1) and combined FNP–PEG treatments (10 ng mL−1 FNP + PEG, 100 ng mL−1 FNP + PEG, and 1000 ng mL−1 FNP + PEG) during 72, 96, 120, and 144 h (from left–right). Germination percentage is calculated for period of 72 to 144 h. Values are means ± S.D. (n = 3). The different letters indicate statistically significant differences among the mean values of different treatments at p < 0.05 using Tukey’s post-hoc test.
Figure 3Shoot length under drought (PEG), fullerol C60(OH)24 nanoparticles (FNP; 0, 10, 100 and 1000 ng mL−1) and combined FNP–PEG treatments (10 ng mL−1 FNP+ PEG, 100 ng mL−1 FNP + PEG, and 1000 ng mL−1 FNP + PEG) during 72, 96, 120 and 144 h (from left–right). Shoot length is measured from period of 72 to 144 hr. Photos represent average shoot length for all treatment after 144 hr. Values are means ± S.D. (n = 3). The different letters indicate statistically significant differences among the mean values of different treatments at p < 0.05 using Tukey’s post-hoc test.
Figure 4Principal component analysis (PCA) of data sets of morphometric parameters under drought (PEG), fullerol C60(OH)24 nanoparticles (FNP; 10, 100, and 1000 ng mL−1) and combined FNP–PEG treatments (10 ng mL−1 FNP + PEG, 100 ng mL−1 FNP + PEG, and 1000 ng mL−1 FNP + PEG). Scores of the first two factors. Black letters present control; red letters present drought. PCA was used to distinguish the effect of single treatment application (control, drought or nanoparticles) and combined drought-nanoparticle treatment. Values are means ± S.D. (n = 3). The different letters indicate statistically significant differences among the mean values of different treatments at p < 0.05 using Tukey’s post-hoc test. ▪ Active data.
Activity of antioxidative enzymes and TBARS content under drought (PEG), fullerol C60(OH)24 nanoparticles (FNP; 0, 10, 100, and 1000 ng mL−1) and combined FNP–PEG treatments (10 ng mL−1 FNP + PEG, 100 ng mL−1 FNP + PEG, and 1000 ng mL−1 FNP + PEG).
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Values are means ± S.D. (n = 3). The different letters indicate statistically significant differences between treatments at p < 0.05, using Tukey’s post-hoc test. APX—ascorbate peroxidase (EC 1.11.1.11); CAT—catalase (EC 1.11.1.6); POD—nonspecific peroxidase (EC 1.11.1.7); PPO—polyphenol oxidase (EC 1.14.18.1); TBARS—thiobarbituric acid reactive substances.
Means of area under healthy tissue progress curve (AUHPC) and standardized area under disease progress curve (AUDPC standard) from Petri-dish test after inoculation of fullerol C60(OH)24 nanoparticles (FNP) pre-treated wheat genotype BC Tena with Aspergillus flavus NRRL 3251.
| Treatment | AUHPC | AUDPCStandard |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Values are represented as means ± SEM (n = 3). The different letters indicate statistically significant differences between treatments at p < 0.05, using Tukey’s post-hoc test.
The A. flavus secondary metabolite profile after the infection of fullerol C60(OH)24 nanoparticles (FNP) pre-treated (0, 1, 10, 100, and 1000 ng mL−1) BC Tena wheat genotype. Data expressed as ng mL−1 represent the mean ± SEM from three separate experiments.
| Treatment | ||||||
|---|---|---|---|---|---|---|
| (ng mL−1) | ||||||
| Control; 0 ng mL−1 FNP |
|
|
|
|
|
|
| Control, 0 ng mL−1 FNP + |
|
|
|
|
|
|
| 10 ng mL−1 FNP |
|
|
|
|
|
|
| 100 ng mL−1 FNP |
|
|
|
|
|
|
| 1000 ng mL−1 FNP |
|
|
|
|
|
|
| FNP 10 ng mL−1 FNP + |
|
|
|
|
|
|
| FNP 100 ng mL−1 FNP + |
|
|
|
|
|
|
| FNP 1000 ng mL−1 FNP + |
|
|
|
|
|
|
Values are represented as means ± SEM (n = 3). The different letters in each column indicate statistically significant differences between treatments at p < 0.05, using Tukey’s post-hoc test.